Consolidated Balance Sheets Statement (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Cash and Cash Equivalents, at Carrying Value	$ 23,220	$ 19,226
Accounts Receivable, Net	190,867	184,774
Inventory, Net	54,831	49,265
Prepaid Expense, Current	15,538	14,959
Income Taxes Receivable, Current	11,183	17,943
Prepaid Expense and Other Assets	13,045	10,740
TOTAL CURRENT ASSETS	308,684	296,907
Property, Plant and Equipment, Net	130,829	125,418
Intangible Assets, Net (Excluding Goodwill)	10,340	8,721
Goodwill	163,337	163,337
Deferred Tax Assets, Net, Noncurrent	9,980	13,224
Other Assets, Noncurrent	31,946	28,909
TOTAL ASSETS	655,116	636,516
Accounts Payable, Current	55,928	55,168
Employee-related Liabilities, Current	30,124	34,919
Sales and Excise Tax Payable, Current	10,288	11,787
Deferred Revenue, Current	16,358	13,868
Taxes Payable, Current	12,157	9,542
Other Accrued Liabilities, Current	16,101	15,226
TOTAL CURRENT LIABILITIES	140,956	140,510
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	250,013	234,033
Deferred Compensation Liability, Classified, Noncurrent	31,470	28,112
Deferred Tax Liabilities, Noncurrent	5,241	6,777
Other Liabilities, Noncurrent	39,958	39,171
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	1,233	1,233
Additional Paid in Capital, Common Stock	110	0
Retained Earnings (Accumulated Deficit)	447,612	361,255
Accumulated Other Comprehensive Income (Loss), Net of Tax	(8,210)	(8,413)
Treasury shares (at cost), xxx at 2011 and 4,218,726 at 2010	(259,432)	(171,845)
Total Core Laboratories N.V. shareholders' equity	181,313	182,230
Stockholders' Equity Attributable to Noncontrolling Interest	6,165	5,683
TOTAL EQUITY	187,478	187,913
TOTAL LIABILITIES AND EQUITY	$ 655,116	$ 636,516